This idea would be consistent with the previous findings that loss-of-function mutations in only SAMD9 cause NFTC in humans [15] and that knockdown of SAMD9 was sufficient for abolishing the restriction for vK1L-C7L- in several human cell lines [14, 26]. Here, SAMD9 is linked to normophosphatemic familial tumoral calcinosis.